Examination for the effect of eldecalcitol on muscle strength in primary osteoporotic patients

Examination for the effect of eldecalcitol on muscle strength in primary osteoporotic patients - Effect of eldecalcitol on muscle strength

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008464

Enrollment

160

Registered

2012-07-18

Start date

2012-07-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Interventions

bisphosphonate + eldecalcitol for 24 weeks bisphosphonate for 24 weeks

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Primary osteoporotic patients 2. Japanese osteoporotic women aged from 55 to 75

Exclusion criteria

Exclusion criteria: 1. Patients with contraindication for bisphosphonate treatments 2. Patients with contraindication for eldecalcitol treatments 3. Patients who are treated with active vitamin D drugs within 8 weeks 4. Patients who have serum calcium levels of above 10.5mg/dL 5. Patients who are inappropriate for this study by physician

Design outcomes

Primary

Measure	Time frame
At baseline and after 24 weeks follow up, the following assessments are done. back muscle strength, hand grip strength, quadriceps muscle strength	—

Secondary

Measure	Time frame
lumbar spine bone mineral density hip bone mineral density 25(OH)D one leg stand test, walking test, timed up and go test, number of falls, active mass, QOL, Safety	—

Countries

Japan

Contacts

Public ContactTakeshi Saito

NTT East Tohoku Hospital Orthopedic Surgery

takeshi.s@east.ntt.co.jp022-236-5945

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026